Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | +2.87% | +0.20% | +15.94% |
Sales 2024 * | 231M 315M | Sales 2025 * | 233M 318M | Capitalization | 242M 331M |
---|---|---|---|---|---|
Net income 2024 * | 13M 17.77M | Net income 2025 * | 14M 19.14M | EV / Sales 2024 * | 1.05 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.04 x |
P/E ratio 2024 * |
19.4
x | P/E ratio 2025 * |
29.7
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.88% |
Latest transcript on Puma Biotechnology, Inc.
1 day | +2.87% | ||
1 week | +0.20% | ||
Current month | -5.28% | ||
1 month | -10.36% | ||
3 months | +3.08% | ||
6 months | +114.53% | ||
Current year | +15.94% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 5.02 | +2.87% | 167,412 |
24-04-25 | 4.88 | +1.04% | 231,234 |
24-04-24 | 4.83 | -5.85% | 365,894 |
24-04-23 | 5.13 | -0.77% | 293,869 |
24-04-22 | 5.17 | +3.19% | 265,410 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.94% | 242M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PBYI Stock